# Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization

> **NCT03802461** · PHASE2,PHASE3 · SUSPENDED · sponsor: **Susy Hota** · enrollment: 40 (estimated)

## Conditions studied

- Infection

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation (FMT)

## Key facts

- **NCT ID:** NCT03802461
- **Lead sponsor:** Susy Hota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-03-22
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-03-20
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Temporarily on hold due to COVID-19 pandemic
- **Last updated:** 2022-11-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802461, "Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03802461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*